Coronary heart disease and ischemic stroke polygenic risk scores and atherosclerotic cardiovascular disease in a diverse, population-based cohort study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 05 08 2022
accepted: 18 04 2023
medline: 19 6 2023
pubmed: 16 6 2023
entrez: 16 6 2023
Statut: epublish

Résumé

The predictive ability of coronary heart disease (CHD) and ischemic stroke (IS) polygenic risk scores (PRS) have been evaluated individually, but whether they predict the combined outcome of atherosclerotic cardiovascular disease (ASCVD) remains insufficiently researched. It is also unclear whether associations of the CHD and IS PRS with ASCVD are independent of subclinical atherosclerosis measures. 7,286 White and 2,016 Black participants from the population-based Atherosclerosis Risk in Communities study who were free of cardiovascular disease and type 2 diabetes at baseline were included. We computed previously validated CHD and IS PRS consisting of 1,745,179 and 3,225,583 genetic variants, respectively. Cox proportional hazards models were used to test the association between each PRS and ASCVD, adjusting for traditional risk factors, ankle-brachial index, carotid intima media thickness, and carotid plaque. The hazard ratios (HR) for the CHD and IS PRS were significant with HR of 1.50 (95% CI: 1.36-1.66) and 1.31 (95% CI: 1.18-1.45) respectively for the risk of incident ASCVD per standard deviation increase in CHD and IS PRS among White participants after adjusting for traditional risk factors. The HR for the CHD PRS was not significant with an HR of 0.95 (95% CI: 0.79-1.13) for the risk of incident ASCVD in Black participants. The HR for the IS PRS was significant with an HR of 1.26 (95%CI: 1.05-1.51) for the risk of incident ASCVD in Black participants. The association of the CHD and IS PRS with ASCVD was not attenuated in White participants after adjustment for ankle-brachial index, carotid intima media thickness, and carotid plaque. The CHD and IS PRS do not cross-predict well, and predict better the outcome for which they were created than the composite ASCVD outcome. Thus, the use of the composite outcome of ASCVD may not be ideal for genetic risk prediction.

Identifiants

pubmed: 37327218
doi: 10.1371/journal.pone.0285259
pii: PONE-D-22-21997
pmc: PMC10275447
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0285259

Subventions

Organisme : NCRR NIH HHS
ID : UL1 RR025005
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL059367
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL086694
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG004402
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002I
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL087641
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146860
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003C
Pays : United States

Informations de copyright

Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2017 Jul 11;12(7):e0179234
pubmed: 28700596
Ultrasound Med Biol. 1996;22(7):791-9
pubmed: 8923698
Am J Hum Genet. 2020 May 7;106(5):707-716
pubmed: 32386537
Stroke. 2008 May;39(5):1586-9
pubmed: 18340101
J Am Coll Cardiol. 2010 Apr 13;55(15):1600-7
pubmed: 20378078
Atherosclerosis. 1997 May;131(1):115-25
pubmed: 9180252
Ann Neurol. 2018 Dec;84(6):934-939
pubmed: 30383316
Curr Atheroscler Rep. 2018 Jul 18;20(9):47
pubmed: 30022313
JAMA. 2020 Feb 18;323(7):636-645
pubmed: 32068818
Arch Intern Med. 2002 Dec 9-23;162(22):2565-71
pubmed: 12456228
Neurology. 2014 Mar 25;82(12):1080-2
pubmed: 24663229
Nat Genet. 2018 Apr;50(4):524-537
pubmed: 29531354
BMC Cardiovasc Disord. 2006 Feb 21;6:7
pubmed: 16504033
Lancet. 2015 Jun 6;385(9984):2264-2271
pubmed: 25748612
Arch Med Res. 2015 Jul;46(5):328-38
pubmed: 26135634
BMC Public Health. 2019 Aug 14;19(1):1112
pubmed: 31412823
J Thromb Haemost. 2012 Aug;10(8):1508-14
pubmed: 22702842
Hum Mol Genet. 2020 May 28;29(8):1388-1395
pubmed: 32219344
Front Cardiovasc Med. 2018 Mar 14;5:19
pubmed: 29740590
Int J Epidemiol. 2015 Apr;44(2):682-8
pubmed: 25953786
J Am Heart Assoc. 2018 Jun 28;7(13):
pubmed: 29954746
Oncotarget. 2017 Aug 18;8(42):72801-72817
pubmed: 29069827
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
Nat Genet. 2020 Nov;52(11):1169-1177
pubmed: 33020668
Sci Rep. 2018 May 1;8(1):6853
pubmed: 29717161
J Am Heart Assoc. 2017 Feb 14;6(2):
pubmed: 28196817
BMJ. 2018 Oct 24;363:k4168
pubmed: 30355576
Genome Biol. 2018 Nov 14;19(1):179
pubmed: 30424772
Nat Genet. 2019 Apr;51(4):584-591
pubmed: 30926966
Nat Rev Genet. 2019 Sep;20(9):520-535
pubmed: 31235872
Genome Med. 2020 May 18;12(1):44
pubmed: 32423490
CJC Open. 2019 Mar 29;1(2):69-75
pubmed: 32159086
Genome Med. 2018 Dec 27;10(1):100
pubmed: 30591078
J Am Coll Cardiol. 2021 Jun 15;77(23):2939-2959
pubmed: 34112321
Circulation. 2020 Feb 25;141(8):637-640
pubmed: 32091922
Thromb Res. 2014 Jun;133(6):993-1005
pubmed: 24448059
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):18924-18933
pubmed: 32753378
Stroke. 2006 Oct;37(10):2493-8
pubmed: 16931783
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893
pubmed: 30309464
Circ Res. 2018 Feb 2;122(3):433-443
pubmed: 29212778
Am J Cardiol. 2021 Jun 1;148:157-164
pubmed: 33675770
Circ Cardiovasc Genet. 2009 Aug;2(4):338-46
pubmed: 20031605
Genet Epidemiol. 2020 Sep;44(6):537-549
pubmed: 32519380
Am J Hum Genet. 2021 Apr 1;108(4):656-668
pubmed: 33770507
Nat Commun. 2019 Dec 20;10(1):5819
pubmed: 31862893
Am J Clin Nutr. 2016 Oct;104(4):1023-1029
pubmed: 27510541
Stroke. 2020 Mar;51(3):759-765
pubmed: 32000589
J Clin Epidemiol. 1996 Feb;49(2):223-33
pubmed: 8606324
Stroke. 2017 Feb;48(2):253-258
pubmed: 28034966
Nat Commun. 2019 Jul 25;10(1):3328
pubmed: 31346163
Genet Epidemiol. 2014 Apr;38(3):265-73
pubmed: 24464495
Cancer Prev Res (Phila). 2018 Dec;11(12):779-788
pubmed: 30327368
Cell. 2019 Oct 17;179(3):589-603
pubmed: 31607513
Cerebrovasc Dis. 2008;26(4):420-4
pubmed: 18799872

Auteurs

Allison Bebo (A)

Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States of America.

Jamie A Jarmul (JA)

Gillings School of Public Health, Department of Health Policy and Management, University of North Carolina, Chapel Hill, Chapel Hill, NC, United States of America.
School of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, NC, United States of America.

Mark J Pletcher (MJ)

Departments of Epidemiology and Biostatistics and Medicine, University of California, San Francisco, San Francisco, CA, United States of America.

Natalie R Hasbani (NR)

Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States of America.

David Couper (D)

Gillings School of Public Health, Department of Biostatistics, University of North Carolina, Chapel Hill, Chapel Hill, NC, United States of America.
Collaborative Studies Coordinating Center, University of North Carolina, Chapel Hill, Chapel Hill, NC, United States of America.

Vijay Nambi (V)

Baylor College of Medicine, Houston, TX, United States of America.
Michael E DeBakey Veterans Affairs Medical Center, Houston, TX, United States of America.

Christie M Ballantyne (CM)

Baylor College of Medicine, Houston, TX, United States of America.

Myriam Fornage (M)

Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States of America.
McGovern Medical School Institute of Molecular Medicine Research Center for Human Genetics, Houston, TX, United States of America.

Alanna C Morrison (AC)

Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States of America.

Christy L Avery (CL)

Gillings School of Public Health, Department of Epidemiology, University of North Carolina, Chapel Hill, Chapel Hill, NC, United States of America.
Carolina Population Center, University of North Carolina-Chapel Hill, Chapel Hill, NC, United States of America.

Paul S de Vries (PS)

Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH